Aspocid 300mg
Each tablet contains : Acetylsalicylic acid 300 mg .
Company Name
CID
Therapeutic Group
NON-NARCOTIC ANALGESICS
Pharmaceutical form
Tablet
Package
A carton box containing 200 tablets ( 20 strips 10 tablets of each )
Indications
- Pain . - Pyrexia (antipyretic ) . - Rheumatic diseases . - Musculoskeletal pain . - Dysmenorrhea . - Anti-platelet for initial treatment of cerebrovascular diseases or myocardial infarction
Warning & Precautions
* Acetyl salicylates should be used cautiously in the following cases: • Uncontrolled hypertension . • Elderly. • Asthmatic patients. • Renal or hepatic impairment. • Glucose-6- phosphate dehydrogenase deficiency. • Children under 12 years old. *All NSAIDs are contraindicated in Pregnancy especially in last trimester (unless potential benefits overweigh risks). * It is contraindicated during lactation to avoid risk of Reye's syndrome in infants.
Product Type
human
Dosage
Usual dose : 1 – 2 tablets to be taken preferably after food this dose may be repeated every (4-6)hours if needed , maximum 4 gm daily . *For initial treatment of cerebrovascular diseases or myocardial infarction : one tablet of Aspocid 300 to be taken once daily till reaching the desirable effect, then Aspocid 75 mg should be instituted as long term prophylaxis therapy
Adverse Reactions
Generally mild and infrequent including : - GIT irritation (can be reduced by taking drug after food) - Skin and bronchospastic reactions in patients who have hypersensitivity to NSAIDs. - Increased bleeding time .
Contra Indications
Breast-feeding . - Gastro–intestinal ulceration . - Hemophilia - Gout . - History of hypersensitivity to aspirin and other NSAIDs. - Bronchial asthma .
Drug Interactions
- The risk of gastrointestinal bleeding and ulceration associated with aspirin is increased when used with corticosteroids. - Aspirin may enhance the activity of coumarin anticoagulants, sulfonylurea hypoglycemic drugs, methotrexate, phenytoin and valproate. - Reduces the diuretic effect of spironolactone . - Reduces the excretion of acetazolamide ( increased risk of toxicity ). - Avoid concurrent administration with NSAIDs.
No comments:
Post a Comment